By Claire Horner In 2016, a law firm in California began looking for individuals who were “misled or harmed by stem cell treatment” in the southern California area (which was discussed on this blog here). While there had been other lawsuits filed by plaintiffs against individual clinics, this firm was looking to take a different […]
The stem cell clinic StemGenex was sued almost a year ago related to allegations about their marketing claims. This proposed class action suit, Moorer v. StemGenex, now includes five named patients involved as one can see from the new fourth amended complaint court document. The five total named patients involved in the suit include four new
Lawsuit against stem cell clinic StemGenex expands to 5 patients Read More »
University of Minnesota bioethicist Leigh Turner has been threatened with a lawsuit by a stem cell clinic-related business. Lawsuit threats in this arena come up every so often and as much as they are unpleasant realities, they can also reveal some important aspects of the stem cell arena. Ars Technica reported yesterday that Leigh’s recent paper
Stem cell clinic-related biz threatens researcher with lawsuit, wants retraction Read More »
Stem cell clinic biotech Stemedica has just been sued by one of its own board members based on allegations related to money the company raised, according to CourtHouseNews. The actual suit, filed by an investment company Tiara Holdings and board member Anthony Marlon, can be read here. CourtHouseNews writes: “Tiara Holdings II LLC sued Stemedica Cell
Stemedica sued by board member over alleged mishandling of funds Read More »
Brigham and Women’s Hospital cardiac stem cell researcher Piero Anversa along with collaborator Annarosa Leri (pictured) are suing both the hospital and Harvard Medical School as well as leaders at the institutions over a research misconduct investigation focused on Anversa and Leri. Boston Globe reporter Carolyn Johnson has been covering Anversa and for background on this new
Harvard Sued by Anversa Over Stem Cell Paper Misconduct Investigation Read More »
A long-standing debate in the commercial stem cell arena has focused on whether stem cells grown in a lab prior to clinical use as a transplantation product are biological drugs subject to full FDA vetting. The alternative view has been that such stem cell products are not drugs, but rather are simple human cellular and
Court in Regenerative Sciences Case: Propagated Stem Cells Are Drugs Read More »
About a year ago, I heard from multiple credible sources that there were ongoing federal probes into potential criminal activities related to bogus or dangerously noncompliant stem cell medical interventions, which could lead to prison time. Since then it has been relatively quiet….that is until the last couple months when again I am hearing from
What would federal prison be like for a non-compliant stem cell doc? Read More »
Today the Supreme Court agreed to review three cases, none of which were Sherley v Sebelius. What a great day! For those curious, Certiorari Granted (subheading on Supreme Court announcement) means the Court has granted review of these cases. This is wonderful news for patients, the stem cell field, and probably biotech Advanced Cell Technology
Great news as Sherley v Sebelius officially over: Supreme Court Takes a pass Read More »
There was a burst of feeling last night in the stem cell community as word began circulating that a federal court had ruled in favor of the FDA defining manipulated stem cell products as drugs. However, not everyone was pleased with the court ruling. The clinics most directly affected by the ruling were understandably upset,
Refuting potential downsides to stem cell drug court ruling Read More »
It’s only Wednesday and it’s already been a big, bumpy week for Texas stem cell company, Celltex. On Monday, the FDA report of their two-week visit to/audit of Celltex became public thanks to the efforts of Dr. Leigh Turner and Houston Chronicle reporter, Todd Ackerman. Now there is more complicated news for the company. A
Celltex is sued by former employee Read More »